U.S. Markets close in 39 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.64 | 132.48 | 1.28% |
| NASDAQ | 2,175.08 | 29.04 | 1.35% |
| S&P 500 | 1,106.21 | 14.83 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 23.2301 02:11 PM EST | |
|---|---|---|
| Day High | 24.29 10:00 AM EST |
|
| Range | 1.06 |
| Volume | 529,718 | |
|---|---|---|
| 30-Day Avg Vol | 814,000 |
|
| Difference | -34.92% |
| Market Cap | 1.15 B | |
|---|---|---|
| Mkt Cap Chg | -1.97 M |
| Shares Out | 49.34 M | |
|---|---|---|
| % Shrs Traded | 1.07% | |
| 1yr EPS Est | -0.141 |
| 52-Wk Low | 6.14 | |
|---|---|---|
| 52-Wk High | 24.29 10:00 AM EST |
|
| Range | 18.15 |
| Prev Close | 23.41 11/20/09 | |
|---|---|---|
| Today's Open | 23.68 | |
| Change | 1.15% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.3 M |
| Revenue (LFY) | 178.76 M | |
|---|---|---|
| Earnings (LFY) | -47.04 M | |
| Earnings (MRQ) | -7.32 M | |
| Next Earn Est | -0.143 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.98 | |
| 1yr EPS Growth | 85.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -16.00 | |
| PEG Ratio | -0.37 | |
| Return on Equity | -17.22 | |
| Beta | 0.79 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Salix Pharmaceuticals is a finishing school for tummy drugs. Focusing on drugs for gastrointestinal diseases, the company shops for drug candidates nearing commercial viability. It then takes them through ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.143 3/8/10 | — — |
—
—
|
| Last Quarter | -0.287 9/30/09 | -0.15 9/30/09 |
0.137
Beat
|
| 2 Quarters Ago | -0.351 6/30/09 | -0.32 6/30/09 |
0.031
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 65.66 M | 178.77 M |
| Gross Profit | 49.89 M | 125.06 M |
| Operating Income | -5.88 M | -46.66 M |
| Net Income | -7.32 M | -47.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts